Gloor, Monika
Andelova, Michaela
Gaetano, Laura
Papadopoulou, Athina
Burguet Villena, Federico
Sprenger, Till
Radue, Ernst-Wilhelm
Kappos, Ludwig
Bieri, Oliver
Garcia, Meritxell http://orcid.org/0000-0001-7946-4657
Funding for this research was provided by:
Swiss Multiple Sclerosis Society (Swiss Multiple Sclerosis Society)
University of Zurich
Article History
Received: 20 April 2023
Revised: 2 July 2023
Accepted: 12 July 2023
First Online: 2 September 2023
Declarations
:
: The scientific guarantor of this publication is Prof. Dr. Oliver Bieri.
: The authors of this manuscript declare relationships with the following companies: Currently, Dr. Laura Gaetano is an employee of Novartis. However, this work has been performed before she changed to Novartis. Therefore, her current company has not been involved in the study.
: Two of the authors (Dr. Monika Gloor and Prof. Dr. Oliver Bieri) have significant statistical expertise.
: Written informed consent was obtained from all subjects (patients) in this study.
: Institutional Review Board approval was obtained by the ethics committee of the University of Basel, now EKNZ (Ethikkommission Nordwest- und Zentralschweiz).
: The subjects or cohorts have not been previously reported anywhere.
: • prospective• observational• performed at one institution